Tag: drug
-
Clovis’s ovarian cancer drug wins accelerated FDA approval
(Reuters) – The U.S. Food and Drug Administration said on Monday it granted accelerated approval to Clovis Oncology Inc's ovarian cancer drug in patients whose disease advanced despite chemotherapy. The drug, Rubraca, secured approval for patients whose tumors have a specific gene mutation called BRCA – identified by an FDA-approved companion diagnostic test, the FDA…
-
Ducks culled in Bulgaria after bird flu found on three farms
More than 4,000 ducks were culled in Bulgaria over the past few days after bird flu was found on three farms, the Bulgarian food safety agency said on Monday. “They were killed after a virulent bird flu was discovered,” Martin Radev, the agency spokesman said. “Most probably, it is H5N8 but I am still not…
-
Fewer deaths and complications with female physicians?
Elderly hospital patients may be less likely to die prematurely or be readmitted for serious complications when they’re treated by female physicians, a U.S. study suggests. With female doctors, patients had 4 percent lower odds of dying within a month after being admitted to the hospital and a 5 percent smaller chance of repeat hospitalizations…
-
Denver to become first U.S. city to legalize social marijuana use
The announcement comes amid a string of victories for proponents of medical and recreational marijuana use, with voters in California and Massachusetts approving ballot initiatives legalizing recreational use of the drug last week. The Colorado measure will permit private businesses to allow marijuana use by adults in designated areas with certain exceptions. Backers of the…
-
FDA highlights liver safety issues in Cempra drug review
(Reuters) – Cempra Inc’s experimental drug to treat community acquired pneumonia, the kind suffered by presidential candidate Hillary Clinton recently, causes a potentially concerning rise in liver enzymes, according to a preliminary review by the U.S. Food and Drug Administration. The review, posted on the FDA’s website on Wednesday, comes two days ahead of a…
-
FDA highlights liver safety issues in Cempra drug review
(Reuters) – Cempra Inc’s experimental drug to treat community acquired pneumonia, the kind suffered by presidential candidate Hillary Clinton recently, causes a potentially concerning rise in liver enzymes, according to a preliminary review by the U.S. Food and Drug Administration. The review, posted on the FDA’s website on Wednesday, comes two days ahead of a…
-
Kite immunotherapy drug helps blood cancer patients in study
(Reuters) – Kite Pharma Inc on Monday said its experimental CAR T-cell therapy, which helps the immune system fight cancer, was highly effective in treating aggressive non-Hodgkin lymphoma, although two deaths were related to the drug, according to interim data from a midstage trial. Shares of Kite, which had been halted before the release of…
-
More U.S. babies born addicted to opiates like heroin
By Lisa Rapaport (Reuters Health) – The proportion of U.S. babies born suffering from withdrawal syndrome after exposure to heroin or prescription opiates in utero has more than doubled in less than a decade, a study suggests. Researchers focused on what’s known as neonatal abstinence syndrome, a condition akin to withdrawal that develops when babies…
-
Astrazeneca says Forxiga combination beats use of drug alone
AstraZeneca said combining its Forxiga type-2 diabetes drug with older medicine Bydureon was more effective at controlling blood sugar levels than treatment with either drug on its own. In a late stage trial, Forxiga and Bydureon were tested on patients whose blood sugar levels could no longer be sufficiently kept in check under an initial…
-
Astrazeneca says Forxiga combination beats use of drug alone
AstraZeneca said combining its Forxiga type-2 diabetes drug with older medicine Bydureon was more effective at controlling blood sugar levels than treatment with either drug on its own. In a late stage trial, Forxiga and Bydureon were tested on patients whose blood sugar levels could no longer be sufficiently kept in check under an initial…